Scandinavian Medical Solutions A/S

As of March 31, 2026, Scandinavian Medical Solutions A/S carries a market capitalization of 90.65M, placing it among publicly traded companies globally. Its enterprise value stands at 163.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Scandinavian Medical Solutions A/S has 27.81M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Scandinavian Medical Solutions A/S maintains a current ratio of 1.46, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Scandinavian Medical Solutions A/S's stock has declined approximately 43.05% over the past 52 weeks. The 50-day moving average sits at 2.59, while the 200-day moving average is 3.06.

As of March 31, 2026, Scandinavian Medical Solutions A/S holds 1.45M in cash and equivalents against 73.98M in total debt, resulting in a net debt position of 28.71M. Total book value stands at 72.85M, with working capital of 40.62M providing operational flexibility.